Streetbeat News

Products Services

XPEV

XPeng Aeroht, affiliated with Chinese EV manufacturer Xpeng Inc (NYSE:XPEV), has successfully tested a multi-parachute rescue system for its X2 flying car. The system activates at a height of about 50 meters above ground, enabling the vehicle to land safely at a low speed with no damage. XPeng Chairman He Xiaopeng has announced plans for mass production and customer deliveries of the X2 flying car by 2024.

Portfolio Pulse from Anan Ashraf

October 21, 2023 | 8:33 am

TSLA

The Tesla Inc (NASDAQ:TSLA) 2024 Model Year VIN decoder on the U.S. auto regulator NHTSA's website reveals two versions of the upcoming Cybertruck. The document submitted to the NHTSA indicates that the Cybertruck will be available in dual motor standard and triple motor performance variants. The first Cybertruck deliveries are scheduled for November 30 at Tesla's gigafactory in Texas.

Portfolio Pulse from Anan Ashraf

October 21, 2023 | 7:24 am

TSLA

Tesla Inc (NASDAQ:TSLA) has reached the milestone of 1 million vehicles delivered in Europe, despite a 10% slump in new car registrations in September. The company's market share dropped to 2.8% last month. This comes amidst an overall surge in EU battery electric car registrations by 14.3%. Other automakers such as Volkswagen, Stellantis NV, and Renault Group saw a significant increase in new car registrations in September, while Ford Motor Co, Mitsubishi, and Tesla witnessed a drop.

Portfolio Pulse from Anan Ashraf

October 21, 2023 | 5:41 am

AAPL

Apple Inc. (NASDAQ:AAPL) has seen a 4.5% decline in iPhone 15 sales in China in the first 17 days compared to its predecessor. This follows China's decision to widen restrictions on the use of iPhones by state employees. However, China's vice premier, Ding Duexiang, has expressed willingness to provide Apple with more opportunities as competition with Huawei Technologies intensifies. Apple CEO Tim Cook recently made a surprise visit to Beijing, where he was welcomed to participate in advancing China's digital economy.

Portfolio Pulse from Ananya Gairola

October 21, 2023 | 2:16 am

TRUFF

Red Light Holland's tech subsidiary, Radix Motion, has been granted a U.S. patent for the use of human movement data in psychedelic-assisted therapy. The patent includes using the data to promote positive experiences, prevent negative experiences, personalize patient experiences, and evaluate therapy efficacy. The company plans to file a continuation application to seek additional claims and new patents. The technology does not require sending or storing any video information, protecting patient privacy.

Portfolio Pulse from Lara Goldstein

October 20, 2023 | 9:25 pm

IGC

IGC Pharma, Inc. (NYSE:IGC) has been granted a European Patent for its cannabis-based pain relief solution. The patented method uses a cream base infused with a unique blend of cannabinoids for transdermal absorption, providing pain relief without adverse side effects. The company's CEO, Ram Mukunda, believes this innovative approach has the potential to disrupt the industry and provide investors with a unique opportunity.

Portfolio Pulse from Jelena Martinovic

October 20, 2023 | 9:18 pm

EA

Electronic Arts Inc's (NASDAQ:EA) EA Sports FC 24 is facing backlash from the gaming community due to a glitch known as the 'Trickster glitch'. This glitch allows players to score goals effortlessly, disrupting the game's competitive balance. Despite calls for a delay of the Weekend League, EA Sports has only acknowledged the issue and stated it is investigating. Players are demanding punitive action against those who exploited the glitch. This comes on top of controversies related to microtransactions and a decline in launch sales in Europe compared to FIFA 23.

Portfolio Pulse from Franca Quarneti

October 20, 2023 | 8:25 pm

BMRN

The U.S. Food and Drug Administration (FDA) has approved BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) supplemental New Drug Application (sNDA) for VOXZOGO® (vosoritide) to increase linear growth in pediatric patients with achondroplasia. Previously, VOXZOGO was indicated for children who were 5 years of age and older. This expanded indication now includes children of all ages with open growth plates. The company has seen strong patient demand for the medicine worldwide and has secured increased fill-finish commitments in 2024 and beyond to meet this additional demand.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:09 pm

PM

Philip Morris International (PMI) has submitted applications to the U.S. FDA to commercialize its IQOS ILUMA heated tobacco products. The company is seeking an order to market these products as modified risk products that reduce exposure to harmful chemicals. IQOS ILUMA products are currently available in 27 international markets and have demonstrated higher rates of full switching by adults who smoke. PMI will have full rights to commercialize all IQOS products in the U.S. as of April 30, 2024, per an agreement with Altria Group.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:03 pm

PFE

The U.S. Food and Drug Administration (FDA) has approved Pfizer's PENBRAYA, a vaccine for the prevention of the five most common serogroups causing meningococcal disease in adolescents. The vaccine provides the broadest serogroup coverage of any meningococcal vaccine available in the U.S. and could simplify the complex vaccination schedule. The approval is based on data from Phase 2 and Phase 3 trials, demonstrating robust immunogenicity and a favorable safety profile.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 7:36 pm